Showing 7601-7610 of 20409 results for "".
Preventing Allergic Reactions to Peanuts with a Cancer Drug
https://reachmd.com/programs/clinicians-roundtable/preventing-allergic-reactions-to-peanuts-with-a-cancer-drug/18012/Can a blood cancer drug potentially prevent allergic reactions to peanuts? Tune in to find out.Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
https://reachmd.com/programs/neurofrontiers/diagnosing-treating-neurocognitive-disorders-in-the-psychiatric-setting/15385/How can we accurately diagnose neurocognitive disorders? Tune in to this recap from the 2023 American Psychiatric Association Annual Meeting.Clinical and Structural Correlates of COVID-19 Hardship in Latino Adults
https://reachmd.com/programs/clinicians-roundtable/clinical-and-structural-correlates-of-covid-19-hardship-in-latino-adults/36417/Best Contact Lens Strategies of 2025
https://reachmd.com/programs/modern-optometry/best-contact-lens-strategies-of-2025/39996/Chasing Answers: Is There a Link Between Exercise & Psoriasis?
https://reachmd.com/programs/spotlight-psoriasis/chasing-answers-is-there-a-link-between-exercise-and-psoriasis/12255/Can cardiorespiratory exercise prevent the onset of autoimmune diseases such as psoriasis?Recognizing Alzheimer's Disease at the Earliest Stages: Key Signs and Symptoms
https://reachmd.com/programs/alzheimers-disease-towards-early-detection/recognizing-alzheimers-disease-earliest-stages-key-signs-and-symptoms/8319/Dr. Howard Fillit from the Alzheimer's Drug Discovery Foundation discusses keys to early recognition for Alzheimer's disease.The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
https://reachmd.com/programs/project-oncology/sabcs-2025-future-of-hr-her2-breast-cancer-care/36166/The 2025 San Antonio Breast Cancer Symposium (SABCS) brought forward key advances shaping the future of hormone receptor-positive, HER2-negative (HR+ HER−) advanced breast cancer care. From novel trial designs to emerging resistance pathways and supportive care considerations, new data are helping rLong-Term ADHD Treatment: Examining Stimulant Tolerance
https://reachmd.com/programs/neurofrontiers/adhd-treatment-stimulant-tolerance/57148/Stimulant medications can be highly effective for children with ADHD, but why do their benefits sometimes fade over time? Join Dr. James Swanson as he discusses key findings from his study, “Tolerance to Stimulant Medications in the Treatment of Children With ADHD” and explores what long-term medicaManaging High-Risk Subgroups in Metastatic NSCLC
https://reachmd.com/programs/project-oncology/high-risk-subgroups-metastatic-nsclc/49120/Data from recent trials like KEYNOTE-407 and CheckMate 9LA continue to shape treatment strategies for high-risk subgroups in metastatic non-small cell lung cancer (NSCLC). Joining Dr. Charles Turck to discuss how we can manage patients with squamous histology, brain metastases, and low PD-L1 expressHigher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
https://reachmd.com/programs/project-oncology/higher-risk-lowered-age-new-colorectal-cancer-screening-guidelines/10309/The American Cancer Society responds to the rise of colorectal cancer in younger generations with the unveiling of new screening guidelines.